The Japan Pediatric Society has announced that the new coronavirus vaccine for children aged 5 to 17 "recommends vaccination" as an academic society, saying that it has accumulated data on the effectiveness and safety of the Omicron strain. .
The Japan Pediatric Society held an online conference on the 10th and announced that it would 'recommend vaccination' for the new coronavirus vaccine from 5 to 17 years old.
The reasons for
this are that the number of children with severe encephalopathy and myocarditis has increased since the epidemic of the Omicron strain, and that
large-scale studies around the world have shown that children However, it has been confirmed that the effect of preventing aggravation is about 40% to 80%.
In addition,
regarding safety, domestic data have been accumulated, and the incidence of adverse reactions including myocarditis among 12- to 17-year-olds is about the same as that of young adults, and 5- to 11-year-olds Responses tended to be mild, and the benefits of vaccination greatly outweigh the risks.
Akihiko Saito, director of the Japan Pediatric Society, said, ``Even children aged 5 to 11, who currently have low vaccination rates, may become seriously ill or die. I was talking.
On the other hand, if you experience symptoms that may be myocarditis or pericarditis, such as chest pain or shortness of breath, within a few days after vaccination, we ask that you see a doctor immediately.
Regarding the vaccination of children with the new coronavirus, a subcommittee made up of experts from the Ministry of Health, Labor and Welfare announced on the 8th of this month that parents must make efforts to receive vaccinations for children aged 5 to 11. We have decided on a policy to